NeuroSense Therapeutics
NRSN
NRSN
11 hedge funds and large institutions have $181K invested in NeuroSense Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HC
Hurley Capital
New York
|
+$8.1K |
2 |
UBS Group
Zurich,
Switzerland
|
+$2.12K |
3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$928 |
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$305K |
2 |
Jane Street
New York
|
-$77.6K |
3 |
HF
HRT Financial
New York
|
-$77K |
4 |
Morgan Stanley
New York
|
-$48.4K |
5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$24K |